short-course tuberculosis chemotherapy, a 6-month treatment regimen for patients with tuberculosis who would otherwise continue to receive medications for at least 18 to 24 months after sputum has a negative finding for tubercle bacilli. The short course requires a combination of four drugs: isoniazid, rifampin, pyrazinamide, and either ethambutol or streptomycin.
